NCT04007432 Nocturnal Hypoxia in Geriatric Patients After Hip Fracture
| NCT ID | NCT04007432 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Delirium |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2020-11-05 |
| Primary Completion | 2028-11-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2020-11-05 with a primary completion date of 2028-11-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Delirium is a common complication following hip fracture surgery (HFS) in older people. Postoperative hypoxia has also been associated with delirium, but not specifically in geriatric patients. The aim of the study is to demonstrate that post-operative hypoxia is associated with in-hospital complications in patients with HFS.
Eligibility Criteria
Inclusion Criteria: * age over 70 years old, * hospitalized in orthogeriatrics for hip fracture surgery * information about the study and expression of non opposition * Expected hospital stay of 5 nights or more Exclusion Criteria: * patient under guardianship, * any other type of fracture associated, * oxymetry recording not possible (behavioral disorders, night stirring,...)
Contact & Investigator
Kiyoka KINUGAWA
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT04007432 clinical trial?
This trial is open to participants of all sexes, aged 70 Years or older, studying Delirium. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04007432 currently recruiting?
Yes, NCT04007432 is actively recruiting participants. Contact the research team at kiyoka.kinugawa@aphp.fr for enrollment information.
Where is the NCT04007432 trial being conducted?
This trial is being conducted at Paris, France, Paris, France.
Who is sponsoring the NCT04007432 clinical trial?
NCT04007432 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Kiyoka KINUGAWA at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 70 participants.